Enzo Biochem Inc's ability to collect accounts receivable sequentially worsen to 6.71, indicating more challenging environment then in the second quarter 2025, but still, it is a far cry from any concerns. Enzo Biochem Inc's Accounts Receivable average collection period in the Apr 30 2025 quarter, has increased to 54 days, from 50 days, in the Jan 31 2025 quarter.

If we take a look into Healthcare sector 361 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Apr 30 2025 from 2557 to 2594.

What is Receivable Turnover Ratio?
What is Enzo Biochem Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ENZ Receivables Turnover Ratio	(Apr 30 2025) III. Quarter	(Jan 31 2025) II. Quarter	(Oct 31 2024) I. Quarter	(Jul 31 2024) IV. Quarter	(Apr 30 2024) III. Quarter
Y / Y Receivable Change	9.5 %	-17.03 %	-8.11 %	-17.05 %	-59.16 %
Y / Y Revenue Change	-20.19 %	-14.25 %	-20.41 %	-	-50.2 %
Receivable Turnover Ratio (TTM)	6.71	7.27	7.18	7.41	1.05
ENZ's Total Ranking	# 2594	# 2557	# 0	#	#
Accounts Receivable average collection period days	54	50	51	49	349
Seq. Receivable Change	1.51 %	10.49 %	-3.66 %	1.35 %	-23.08 %
Seq. Revenue Change	-12.71 %	18.04 %	-17.45 %	-6.18 %	-6.21 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 25
Healthcare Sector	# 362
Overall Market	# 2594

Receivable Turnover Ratio Statistics
High	Average	Low
1.61	-12.89	-220.58
(Jan 31 2014)		(Jul 31 2023)

ENZ Company Profile • Back to ENZ Efficiency Comparisons • Compare ENZ Receivables Turnover Ratio to its Competitors

Financial Statements
Enzo Biochem Inc's Accounts Receivable	$ 4 Millions	Visit ENZ's Balance sheet
Enzo Biochem Inc's Sales TTM	$ 27 Millions	Visit ENZ's Income Statement
Sources of ENZ's Revenues		Visit ENZ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ENZ's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ENZ's Growth Rates	ENZ's Roa	ENZ's Inventory Turnover Ratio	ENZ's Dividend Comparisons
ENZ's Profitability Ratios	ENZ's Roi	ENZ's Asset Turnover Ratio	ENZ's Dividend Growth
ENZ's Valuation Ratios	ENZ's Roe	ENZ's Financial Strength Ratios	ENZ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Apr 30 2025, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Apr 30 2025	Receivable at quarter ending Apr 30 2025
Milestone Scientific Inc	17.43	$ 8.418 Millions	$ 0.483 Millions
Neuraxis Inc	17.06	$ 2.935 Millions	$ 0.172 Millions
Innovage Holding Corp	16.44	$ 831.684 Millions	$ 50.574 Millions
Silence Therapeutics Plc	16.07	$ 27.701 Millions	$ 1.724 Millions
Spero Therapeutics Inc	15.95	$ 44.584 Millions	$ 2.796 Millions
Generation Bio Co	15.93	$ 24.556 Millions	$ 1.541 Millions
Petvivo Holdings Inc	15.90	$ 1.133 Millions	$ 0.071 Millions
Ontrak Inc	15.28	$ 9.890 Millions	$ 0.647 Millions
Kiniksa Pharmaceuticals International Plc	15.14	$ 481.166 Millions	$ 31.782 Millions
Mannkind Corporation	14.48	$ 297.595 Millions	$ 20.559 Millions
Icu Medical Inc	14.25	$ 2,419.911 Millions	$ 169.876 Millions
Inmed Pharmaceuticals Inc	14.25	$ 4.515 Millions	$ 0.317 Millions
Co diagnostics Inc	14.01	$ 3.498 Millions	$ 0.250 Millions
Biofrontera Inc	13.45	$ 59.599 Millions	$ 4.431 Millions
China Pharma Holdings Inc	13.28	$ 4.295 Millions	$ 0.323 Millions
Newamsterdam Pharma Company N v	13.25	$ 47.140 Millions	$ 3.559 Millions
Grail Inc	13.17	$ 130.711 Millions	$ 9.925 Millions
Rosecliff Acquisition Corp I	13.04	$ 29.581 Millions	$ 2.268 Millions
Quipt Home Medical Corp	13.03	$ 425.431 Millions	$ 32.657 Millions
Day One Biopharmaceuticals Inc	13.02	$ 161.922 Millions	$ 12.440 Millions
Ptc Therapeutics inc	12.99	$ 1,772.758 Millions	$ 136.420 Millions
Voyager Therapeutics Inc	12.89	$ 66.958 Millions	$ 5.196 Millions
Qhslab Inc	12.70	$ 2.289 Millions	$ 0.180 Millions
Vireo Growth Inc.	12.65	$ 99.797 Millions	$ 7.887 Millions
Nrc Health	12.64	$ 141.298 Millions	$ 11.177 Millions
Sangamo Therapeutics Inc	12.57	$ 63.756 Millions	$ 5.071 Millions
Longeveron Inc	12.52	$ 2.225 Millions	$ 0.178 Millions
Dyadic International Inc	12.07	$ 3.554 Millions	$ 0.294 Millions
Protalix Biotherapeutics inc	12.01	$ 59.764 Millions	$ 4.976 Millions
Corcept Therapeutics Inc	11.95	$ 685.446 Millions	$ 57.337 Millions

Date modified: 2026-07-07T10:39:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.